AMARIN
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarin’s lead candidate, AMR101, is currently being studied in two concurrently run pivotal Phase 3 trials. These trials are investigating the efficacy of AMR101 in lowering triglycerides in patients with very high triglycerides (>500mg/dl) and in patients with mixed dyslipidemia who are taking statins. Amarin’s cardiovascular programs capitalize on Amarin'... s expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease. Amarin is headquartered in Dublin, Ireland, and has its research and development headquartered in Mystic Connecticut, USA. Amarin is listed in the U.S. on NASDAQ (ticker: AMRN)
AMARIN
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
1991-01-01
Address:
Ballsbridge, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.amarincorp.com
Total Employee:
51+
Status:
Active
Contact:
+353 1 669 9020
Email Addresses:
[email protected]
Total Funding:
122.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Apache
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-12-05 | Ester Neurosciences | Ester Neurosciences acquired by Amarin | N/A |
Investors List
Abingworth
Abingworth investment in Post-IPO Equity - Amarin
Fountain Healthcare Partners
Fountain Healthcare Partners investment in Post-IPO Equity - Amarin
OrbiMed
OrbiMed investment in Post-IPO Equity - Amarin
Longitude Capital
Longitude Capital investment in Post-IPO Equity - Amarin
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Amarin
Newest Events participated
Participated in 12th Annual Cardiometabolic Health Congress
on 2017-10-04 as exhibitor
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-06 | Amarin Appoints Tom Reilly as New Chief Financial Officer |
| 2021-04-13 | With crucial EU launch rolling, Amarin's Thero hands CEO baton to new European commercial chief |
Official Site Inspections
http://www.amarincorp.com Semrush global rank: 1.7 M Semrush visits lastest month: 14.22 K
- Host name: 172.67.16.38
- IP address: 172.67.16.38
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
